JPH11335328A - Production of 3,5-dihydroxy-6-oxohexanoic acid ester derivative - Google Patents

Production of 3,5-dihydroxy-6-oxohexanoic acid ester derivative

Info

Publication number
JPH11335328A
JPH11335328A JP11118170A JP11817099A JPH11335328A JP H11335328 A JPH11335328 A JP H11335328A JP 11118170 A JP11118170 A JP 11118170A JP 11817099 A JP11817099 A JP 11817099A JP H11335328 A JPH11335328 A JP H11335328A
Authority
JP
Japan
Prior art keywords
derivative
dihydroxy
group
formula
dihydroxyadipate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP11118170A
Other languages
Japanese (ja)
Other versions
JP3263377B2 (en
Inventor
Shigeo Hayashi
茂雄 林
Noboru Kamiyama
昇 上山
Kenji Inoue
健二 井上
里美 ▲高▼橋
Satomi Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanegafuchi Chemical Industry Co Ltd
Original Assignee
Kanegafuchi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanegafuchi Chemical Industry Co Ltd filed Critical Kanegafuchi Chemical Industry Co Ltd
Priority to JP11817099A priority Critical patent/JP3263377B2/en
Publication of JPH11335328A publication Critical patent/JPH11335328A/en
Application granted granted Critical
Publication of JP3263377B2 publication Critical patent/JP3263377B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROBLEM TO BE SOLVED: To industrially and advantageously produce the subject derivative useful as an intermediate for a therapeutic agent for hyperlipemia by regioselectively reducing a specific derivative. SOLUTION: A 2,4-dihydroxyadipic acid ester derivative represented by formula I (R<1> is an ester, carboxyl or the like; R<2> is an alkyl, an aryl or an aralkyl; R<3> and R<4> are each H, a silyl type protecting group or the like) is regioselectively reduced to produce the objective derivative represented by formula II (e.g. t-butyl 3,5-O-isopropylidene-3,5-dihyciroxy-6-oxohexanoate). In the reduction, a hydride reducing agent, e.g. diisobutylaluminum hydride is preferably used as a reducing agent. Furthermore, the reaction is preferably conducted in, e.g. an inert aprotic solvent at -90 to -50 deg.C.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、3,5−ジヒドロ
キシ−6−オキソヘキサン酸エステル誘導体の製造法に
関し、とりわけその光学活性体を有利に製造する方法に
関するものである。
The present invention relates to a method for producing a 3,5-dihydroxy-6-oxohexanoic acid ester derivative, and more particularly to a method for advantageously producing an optically active substance thereof.

【0002】このようなヘキサン酸エステル誘導体は、
抗脂血症治療薬としての作用が注目されているHMG−
CoA(3−ヒドロキシ−3−メチルグルタリル−CoA)
還元酵素阻害剤の中間体として有用な化合物である。
[0002] Such hexanoic acid ester derivatives are
HMG- attracts attention for its action as a therapeutic agent for antilipidemia
CoA (3-hydroxy-3-methylglutaryl-CoA)
It is a compound useful as an intermediate of a reductase inhibitor.

【0003】[0003]

【従来の技術】3,5−ジヒドロキシ−6−オキソヘキ
サン酸エステル誘導体の製造法としては、3,5,6−ト
リヒドロキシヘキサンエステル誘導体を酸化する事によ
る製造法(特開平1−199945号公報)、及びスチ
レン誘導体のオゾン酸化を利用した方法(ジャーナル・
オブ・メディシナル・ケミストリー(J.Med.Che
m.)33、2982(1980))が知られている。
2. Description of the Related Art As a method for producing a 3,5-dihydroxy-6-oxohexanoic acid ester derivative, a method for oxidizing a 3,5,6-trihydroxyhexane ester derivative (JP-A-1-199945) is known. ) And a method using ozone oxidation of a styrene derivative (Journal
Of Medicinal Chemistry (J. Med. Che
m. ) 33, 2982 (1980)).

【0004】[0004]

【発明が解決しようとする課題】3,5,6−トリヒドロ
キシヘキサン酸エステル誘導体を酸化する方法や、スチ
レン誘導体のオゾン酸化を利用した方法は、比較的高価
な試薬や,煩雑な操作を必要とする等の課題を有してお
り、3,5−ジヒドロキシ−6−オキソヘキサン酸誘導
体の工業的製法としては、更に効果的な方法が望まれ
る。
The method of oxidizing a 3,5,6-trihydroxyhexanoic acid ester derivative and the method of utilizing ozone oxidation of a styrene derivative require relatively expensive reagents and complicated operations. Therefore, a more effective method is desired as an industrial production method of a 3,5-dihydroxy-6-oxohexanoic acid derivative.

【0005】[0005]

【課題を解決するための手段】本発明者らは、かかる実
状に鑑み、経済的で実用性に優れた3,5−ジヒドロキ
シ−6−オキソヘキサン酸エステル誘導体、とりわけそ
れらの光学活性な誘導体である(3R,5S)−3,5−ジ
ヒドロキシ−6−オキソヘキサン酸エステルの製造法に
関して鋭意検討した結果、リンゴ酸から容易に合成でき
る2,4−ジヒドロキシアジピン酸エステル誘導体の1
位エステル基、もしくは1位カルボキシル基、もしくは
その反応性誘導体のいずれかを還元することにより、
3,5−ジヒドロキシ−6−オキソヘキサン酸エステル
誘導体が製造できる事、さらには光学活性L−リンゴ酸
を出発原料に用いて合成した(2S,4R)−2,4−ジヒ
ドロキシアジピン酸エステル誘導体を還元する事によ
り、該ヘキサン酸エステル誘導体の光学活性な(3R,5
S)誘導体を製造できることを見いだし、本発明を完成
した。
In view of the above circumstances, the present inventors have developed economically and practically useful 3,5-dihydroxy-6-oxohexanoic acid ester derivatives, especially optically active derivatives thereof. As a result of intensive studies on a method for producing a certain (3R, 5S) -3,5-dihydroxy-6-oxohexanoic acid ester, one of 2,4-dihydroxyadipate ester derivatives which can be easily synthesized from malic acid was obtained.
By reducing the ester group, or the carboxyl group at the 1-position, or any of its reactive derivatives,
3,5-dihydroxy-6-oxohexanoic acid ester derivative can be produced, and (2S, 4R) -2,4-dihydroxyadipate derivative synthesized using optically active L-malic acid as a starting material. By reduction, the optically active (3R, 5
The present inventors have found that S) derivatives can be produced and completed the present invention.

【0006】即ち、本発明は式(I):That is, the present invention provides a compound of the formula (I):

【化3】 (式中、R1はエステル基、カルボキシ基又はカルボン酸
の反応性誘導体を表す。R2はアルキル基、アリール基
又はアラルキル基を、R3及びR4は水素又はシリル型保
護基、もしくは共同して環を形成していてもよいアルキ
ル基を表す。)で示される2,4−ジヒドロキシアジピン
酸エステル誘導体を位置選択的に還元することを特徴と
する、式(II):
Embedded image (Wherein, R 1 represents an ester group, a carboxy group or a reactive derivative of a carboxylic acid; R 2 represents an alkyl group, an aryl group or an aralkyl group; R 3 and R 4 represent hydrogen or a silyl-type protecting group Wherein the 2,4-dihydroxyadipate derivative represented by the formula (II):

【化4】 (式中、R2、R3及びR4は前記と同意義。)で示される
3,5−ジヒドロキシ−6−オキソヘキサン酸エステル
誘導体の製造法を提供する。
Embedded image (Wherein R 2 , R 3 and R 4 have the same meanings as described above). A process for producing a 3,5-dihydroxy-6-oxohexanoate derivative represented by the formula:

【0007】本発明によると、光学活性なL−リンゴ酸
から容易に合成できる(2S,4R)−2,4−ジヒドロキ
シアジピン酸エステル誘導体を効果的に、HMG−Co
A還元酵素阻害剤中間体として有用な立体配置を有する
(3R,5S)−3,5−ジヒドロキシ−6−オキソヘキサ
ン酸エステル誘導体に変換することができる。本発明の
出発化合物である2,4−ジヒドロキシアジピン酸エス
テル誘導体は例えばリンゴ酸をアセトニド化した後、マ
ロン酸ハーフエステルを用いて増炭し、脱保護、還元
し、更に必要に応じてヒドロキシル基を保護することに
よって製造できる。
According to the present invention, a (2S, 4R) -2,4-dihydroxyadipate derivative which can be easily synthesized from optically active L-malic acid can be effectively converted into HMG-Co.
Has a useful configuration as an intermediate for A reductase inhibitors
It can be converted to (3R, 5S) -3,5-dihydroxy-6-oxohexanoate derivative. The starting compound of the present invention, a 2,4-dihydroxyadipate derivative, is obtained by, for example, malonic acid acetonidation, followed by enrichment with malonic acid half ester, deprotection and reduction, and further, if necessary, a hydroxyl group. Can be manufactured by protecting.

【0008】上記反応は、以下の反応式で示される。The above reaction is represented by the following reaction formula.

【化5】 (式中、R2及びR5はそれぞれアルキル基を、R6及びR
7はそれぞれヒドロキシル基の保護基を表す。)。
Embedded image (Wherein, R 2 and R 5 each represent an alkyl group, R 6 and R 5
7 represents a hydroxyl-protecting group. ).

【0009】式(I)で示される化合物を還元して式(I
I)で示される3,5−ジヒドロキシ−6−オキソヘキサ
ン酸エステル誘導体を製造する場合、R1としては、エ
ステル基、カルボキシル基及びカルボン酸の反応性誘導
体を挙げることができる。エステル基としてはメチル
基、エチル基、プロピル基等の低級アルキル基が挙げら
れ、カルボン酸の反応性誘導体としては当該カルボン酸
より誘導される酸クロライド、混合酸無水物等が挙げら
れる。
The compound of the formula (I) is reduced to give a compound of the formula (I
In the case of producing the 3,5-dihydroxy-6-oxohexanoic acid ester derivative represented by I), examples of R 1 include a reactive derivative of an ester group, a carboxyl group, and a carboxylic acid. Examples of the ester group include lower alkyl groups such as a methyl group, an ethyl group, and a propyl group. Examples of the reactive derivative of the carboxylic acid include an acid chloride and a mixed acid anhydride derived from the carboxylic acid.

【0010】R1の種類に応じて種々の還元法が使用で
きる。例えばR1がエステル基の場合、ジイソブチルア
ルミニウムハイドライド、水素化アルミニウムリチウ
ム、水素化アルミニウムナトリウム、水素化ジイソブチ
ルアルミニウムナトリウム等のヒドリド還元剤を用いる
ことができる。例えばジイソブチルアルミニウムハイド
ライドを用いてエステルをアルデヒドに還元する場合、
反応は好ましくは−90〜−50℃の低温で行われ、ト
ルエン、ヘキサン等の非プロトン性溶媒が用いられる。
Various reduction methods can be used depending on the type of R 1 . For example, when R 1 is an ester group, a hydride reducing agent such as diisobutylaluminum hydride, lithium aluminum hydride, sodium aluminum hydride, or sodium diisobutylaluminum can be used. For example, when reducing an ester to an aldehyde using diisobutylaluminum hydride,
The reaction is preferably performed at a low temperature of -90 to -50C, and an aprotic solvent such as toluene or hexane is used.

【0011】また、R1が酸クロライドを形成する場
合、種々の方法が利用できるが、例えばPd−BaSO4
を触媒に用いて接触還元(ローゼンムント(Rosenmund)
還元)することによってアルデヒドに変換することがで
きる。R1が混合酸無水物を形成する場合、種々の方法
が利用できるが、例えばパラジウム/炭素を触媒として
接触還元することによってアルデヒドに変換することが
できる。また、R1がカルボキシル基の場合、例えばLi
9−BBN等のボラン還元剤を利用することによりア
ルデヒドに変換できる。
When R 1 forms an acid chloride, various methods can be used. For example, Pd—BaSO 4
Reduction using a catalyst as a catalyst (Rosenmund)
Can be converted to an aldehyde. When R 1 forms a mixed acid anhydride, various methods can be used. For example, it can be converted to an aldehyde by catalytic reduction using palladium / carbon as a catalyst. When R 1 is a carboxyl group, for example, Li
It can be converted to an aldehyde by using a borane reducing agent such as 9-BBN.

【0012】[0012]

【実施例】以下に実施例及び参考例を挙げて本発明を更
に詳しく説明するが、もとより本発明はこれに限定され
るものではない。
EXAMPLES The present invention will be described in more detail with reference to the following Examples and Reference Examples, but the present invention is not limited thereto.

【0013】実施例1 3.5−O−イソプロピリデン−3.5−ジヒドロキシ
−6−オキソヘキサン酸t−ブチルの合成 (2S,4R)−2,4−O−イソプロピリデン−2,4−
ジヒドロキシアジピン酸 1−メチル 6−t−ブチル
4.01g(13.9mmol)とトルエン40mlからなる溶
液に、−80℃で水素化ジイソブチルアルミニウムハイ
ドライドの24%トルエン溶液9.6mlを加え、更に−
78℃で1時間撹拌した。水50mlを反応液に加えた
後、1N塩酸を加えてpH2.5に調整し、酢酸エチル
で抽出した(50ml×2)。
Example 1 Synthesis of t-butyl 3.5-O-isopropylidene-3.5-dihydroxy-6-oxohexanoate (2S, 4R) -2,4-O-isopropylidene-2,4-
To a solution of 4.01 g (13.9 mmol) of 1-methyl 6-t-butyl dihydroxyadipate and 40 ml of toluene was added 9.6 ml of a 24% solution of diisobutylaluminum hydride in toluene at -80 ° C.
Stirred at 78 ° C. for 1 hour. After adding 50 ml of water to the reaction solution, the pH was adjusted to 2.5 by adding 1N hydrochloric acid, and the mixture was extracted with ethyl acetate (50 ml × 2).

【0014】無水硫酸ナトリウムで乾燥後、溶媒を減圧
留去し、得られた油状物をシリカゲルのカラムクロマト
グラフィ(ヘキサン:アセトン=5:1)により精製して、
430mgの3,5−O−イソプロピリデン−3,5−ジヒ
ドロキシ−6−オキソヘキサン酸t−ブチルを得た(収率
12%)
After drying over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure, and the resulting oil was purified by silica gel column chromatography (hexane: acetone = 5: 1).
430 mg of t-butyl 3,5-O-isopropylidene-3,5-dihydroxy-6-oxohexanoate were obtained (yield 12%).

【0015】1HNMR(DMSO−d6:CDCl3=3:
1,90mHz):δ1.02−2.97(m,8H),1.40
(s,9H),2.23−2.65(m,2H),3.71−4.
43(m,2H),9.52(brs,1H)
1 H NMR (DMSO-d6: CDCl 3 = 3:
1,90 mHz): δ 1.02-2.97 (m, 8H), 1.40
(s, 9H), 2.23-2.65 (m, 2H), 3.71-4.
43 (m, 2H), 9.52 (brs, 1H)

【0016】参考例1 4−(2,2−ジメチル−5−オキソ−1,3−ジオキソ
ラン−4−イル)−3−オキソ−ブタン酸 t−ブチル
の合成 2,2−ジメチル−5−オキソ−1,3−ジオキソラン−
4−酢酸2.09g(12mmol)とTHF72.0mlから
なる溶液に、アルゴン雰囲気下、カルボニルジイミダゾ
ール2.14g(13.2mmol)を0℃で加えて15分間
撹拌した後、さらに室温で4時間撹拌した。得られた溶
液にビス(マロン酸モノt−ブチルエステル)マグネシウ
ム塩5.35g(15.6mmol)を室温で加え、18時間
撹拌した。THFを減圧留去した後、25%クエン酸水
溶液100mlを加え、酢酸エチルを用いて抽出した。
Reference Example 1 t-butyl 4- (2,2-dimethyl-5-oxo-1,3-dioxolan-4-yl) -3-oxo-butanoate
Synthesis of 2,2-dimethyl-5-oxo-1,3-dioxolane
Under an argon atmosphere, 2.14 g (13.2 mmol) of carbonyldiimidazole was added to a solution consisting of 2.09 g (12 mmol) of 4-acetic acid and 72.0 ml of THF at 0 ° C., and the mixture was stirred for 15 minutes, and further stirred at room temperature for 4 hours. Stirred. 5.35 g (15.6 mmol) of bis (malonic acid mono-t-butyl ester) magnesium salt was added to the obtained solution at room temperature, and the mixture was stirred for 18 hours. After THF was distilled off under reduced pressure, 100 ml of a 25% aqueous citric acid solution was added, and the mixture was extracted with ethyl acetate.

【0017】有機層を150ml飽和NaHCO3水溶液で
洗浄し無水硫酸ナトリウムで乾燥後、溶媒を減圧留去し
た。残渣をシリカゲルカラムクロマト(ヘキサン:酢酸エ
チル=3:1)で単離することにより純粋な4−(2,2−
ジメチル−5−オキソ−1,3−ジオキソラン−4−イ
ル)−3−オキソ−ブタン酸 t−ブチル 3.14g(1
1.5mmol)を得た(収率96.0%)。
The organic layer was washed with 150 ml of a saturated aqueous solution of NaHCO 3 and dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was isolated by silica gel column chromatography (hexane: ethyl acetate = 3: 1) to give pure 4- (2,2-
3.14 g (1) of t-butyl dimethyl-5-oxo-1,3-dioxolan-4-yl) -3-oxo-butanoate
1.5 mmol) (96.0% yield).

【0018】1H−NMR (CDCl3,90MHz):δ
4.71(m,1H),.37(s,2H),3.10(m,2H),
1.61(s,3H),1.56(s,3H),1.46(s,9H)
1 H-NMR (CDCl 3 , 90 MHz): δ
4.71 (m, 1H),. 37 (s, 2H), 3.10 (m, 2H),
1.61 (s, 3H), 1.56 (s, 3H), 1.46 (s, 9H)

【0019】 元素分析:実測値 C57.57%、 H 7.23% 計算値 C57.34%、 H 7.40% (C13206)Elemental analysis: Found C 57.57%, H 7.23% Calculated C 57.34%, H 7.40% (C 13 H 20 O 6 )

【0020】参考例2 2−ヒドロキシ−4−オキソアジピン酸 1−メチル
6−tブチルの合成 4−(2,2−ジメチル−5−オキソ−1,3−ジオキソ
ラン−4−イル)−3−オキソ−ブタン酸 t−ブチル
16.30g(60.08mmol)をトルエン120.0ml
に溶解した後0℃に冷却しアルゴン雰囲気下ナトリウム
メトキシド(1Mメタノール溶液)60.3mlを滴下し
た。0℃で30分間撹拌した後、1N塩酸60.5mlを
滴下し、0℃で10分間撹拌した。有機溶媒の大部分を
減圧留去した後、酢酸エチルで抽出し、飽和食塩水とリ
ン酸緩衝溶液(pH7.0)により洗浄した。
Reference Example 2 1-methyl 2 -hydroxy-4-oxoadipate
Synthesis of 6-tbutyl t-butyl 4- (2,2-dimethyl-5-oxo-1,3-dioxolan-4-yl) -3-oxo-butanoate
16.30 g (60.08 mmol) of toluene 120.0 ml
After cooling to 0 ° C., 60.3 ml of sodium methoxide (1M methanol solution) was added dropwise under an argon atmosphere. After stirring at 0 ° C. for 30 minutes, 60.5 ml of 1N hydrochloric acid was added dropwise and stirred at 0 ° C. for 10 minutes. After most of the organic solvent was distilled off under reduced pressure, the residue was extracted with ethyl acetate, and washed with a saturated saline solution and a phosphate buffer solution (pH 7.0).

【0021】有機層を合わせ、無水硫酸ナトリウムで乾
燥後、溶媒を減圧留去した。残渣をシリカゲルカラムク
ロマトグラフィ(ヘキサン:アセトン=2:1)で単離する
ことにより純粋な2−ヒドロキシ−4−オキソアジピン
酸 1−メチル 6−tブチル13.26g(53.85m
mol)を得た(収率89.6%)。1 H−NMR (CDCl3,90MHz):δ4.52(m,1
H),3.95(br,1H),3.80(s,3H),3.40(s,
2H),3.04(m,2H),1.46(s,9H)
The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was isolated by silica gel column chromatography (hexane: acetone = 2: 1) to give 13.26 g (53.85 m) of pure 1-methyl 2-hydroxy-4-oxoadipate 6-tbutyl.
mol) (89.6% yield). 1 H-NMR (CDCl 3 , 90 MHz): δ 4.52 (m, 1
H), 3.95 (br, 1H), 3.80 (s, 3H), 3.40 (s,
2H), 3.04 (m, 2H), 1.46 (s, 9H)

【0022】 元素分析:実測値 C53.45%、H 7.27% 計算値 C53.65%、H 7.37% (C11186)Elemental analysis: found C 53.45%, H 7.27% Calculated C 53.65%, H 7.37% (C 11 H 18 O 6 )

【0023】参考例3 2,4−ジヒドロキシアジピン酸1−メチル6−tブチル
の合成 THF2.5ml、メタノール5ml、トリエチルホウ素
(1M THF溶液)12ml混合物を、アルゴン雰囲気
下、3時間撹拌した後、−50℃に冷却し、2−ヒドロ
キシ−4−オキソアジピン酸 1−メチル 6−t−ブ
チル 2.46g(10mmol)とTHF2.5mlからなる
溶液を5分間かけて滴下した。−50℃で2時間撹拌し
た後、−78℃に冷却し、水素化ホウ素ナトリウム0.
38g(10mmol)を一度に加え、さらに−78℃で2時
間撹拌した。酢酸3mlを15分かけて−78℃で反応溶
液に滴下した後、更に15分撹拌した。
Reference Example 3 Synthesis of 1-methyl 6-t-butyl 2,4-dihydroxyadipate THF 2.5 ml, methanol 5 ml, triethyl boron
(1M THF solution) 12 ml of the mixture was stirred for 3 hours under an argon atmosphere, cooled to -50 ° C, and 2.46 g (10 mmol) of 1-methyl 6-t-butyl 2-hydroxy-4-oxoadipate was added. A solution consisting of 2.5 ml of THF was added dropwise over 5 minutes. After stirring at −50 ° C. for 2 hours, the mixture was cooled to −78 ° C., and sodium borohydride was added.
38 g (10 mmol) were added in one portion, and the mixture was further stirred at -78 ° C for 2 hours. 3 ml of acetic acid was added dropwise to the reaction solution at -78 ° C over 15 minutes, and the mixture was further stirred for 15 minutes.

【0024】得られた混合物に水5mlを加え、さらに1
5分撹拌した。有機層を減圧留去した後、エタノール1
0mlを加え、さらに10%過酸化水素水1.5mlをゆっ
くりと加えた後、室温で30分撹拌した。5%亜硫酸ナ
トリウム水溶液30mlを加え室温で30分間撹拌した
後、20%水酸化ナトリウムを加えてpH6に調製し
た。CH2Cl2を用いて抽出した(50ml×2)。
5 ml of water was added to the obtained mixture,
Stir for 5 minutes. After evaporating the organic layer under reduced pressure, ethanol 1
After 0 ml was further added and 1.5 ml of a 10% hydrogen peroxide solution was slowly added, the mixture was stirred at room temperature for 30 minutes. After adding 30 ml of a 5% aqueous sodium sulfite solution and stirring at room temperature for 30 minutes, the pH was adjusted to 6 by adding 20% sodium hydroxide. Extracted with CH 2 Cl 2 (50 ml × 2).

【0025】有機層を集めて硫酸ナトリウムで乾燥後、
溶媒を減圧留去した。残渣をシリカゲルカラムクロマト
グラフィ(ヘキサン:アセトン=4:1)で単離することに
より1.97gの2,4−ジヒドロキシアジピン酸 1−
メチル 6−t−ブチル(1.93mmol)を得た(収率79
%)。
After collecting the organic layers and drying over sodium sulfate,
The solvent was distilled off under reduced pressure. The residue was isolated by silica gel column chromatography (hexane: acetone = 4: 1) to give 1.97 g of 2,4-dihydroxyadipate 1-.
Methyl 6-t-butyl (1.93 mmol) was obtained (yield 79).
%).

【0026】1H−NMR (CDCl3,90MHz):δ
4.32(m,2H),3.76(s,3H),3.61(br,2
H),2.42(m,2H),1.97(m,2H),1.46(s,
9H)
1 H-NMR (CDCl 3 , 90 MHz): δ
4.32 (m, 2H), 3.76 (s, 3H), 3.61 (br, 2
H), 2.42 (m, 2H), 1.97 (m, 2H), 1.46 (s,
9H)

【0027】 元素分析:実測値 C53.37%、H 8.23% 計算値 C53.21%、H 8.12% (C11206)Elemental analysis: found C 53.37%, H 8.23% calculated C 53.21%, H 8.12% (C 11 H 20 O 6 )

【0028】参考例4 2−メトキシカルボニル−4−t−ブトキシカルボニル
メチル−6,6−ジメチル−1,5−ジオキサンの合成 2,4−ジヒドロキシアジピン酸1−メチル6−t−ブチ
ル4.98g(20.01mmol)と塩化メチレン21の混
合溶液に、ジメトキシプロパン9.6ml(78mmol)、p
−トルエンスルホン酸ピリジニウム2.01g(8mmol)
を加え、還流条件下、1時間撹拌し、次いでメタノール
を共沸により除去しながら40℃で3時間撹拌した。減
圧濃縮後、得られる残渣を酢酸エチルに溶解した後、水
に注ぎ、酢酸エチルで抽出した。有機層を集めて無水硫
酸ナトリウムで乾燥後、溶媒を減圧留去した。残渣をシ
リカゲルカラムクロマトグラフィ(ヘキサン:アセトン=
3:1)で精製することにより純粋な2−メトキシカルボ
ニル−4−t−ブトキシカルボニルメチル−6,6−ジメ
チル−1,5−ジオキサン4.89g(17.01mmol)を
得た(収率85%)。
Reference Example 4 Synthesis of 2-methoxycarbonyl-4-t-butoxycarbonylmethyl-6,6-dimethyl-1,5-dioxane 4.98 g of 1-methyl-6-t-butyl 2,4-dihydroxyadipate (20.01 mmol) and methylene chloride 21 in a mixed solution, 9.6 ml (78 mmol) of dimethoxypropane, p
2.01 g (8 mmol) of pyridinium toluenesulfonate
Was added, and the mixture was stirred under reflux for 1 hour, and then stirred at 40 ° C. for 3 hours while removing methanol by azeotropic distillation. After concentration under reduced pressure, the obtained residue was dissolved in ethyl acetate, poured into water, and extracted with ethyl acetate. The organic layer was collected, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: acetone =
Purification by 3: 1) gave 4.89 g (17.01 mmol) of pure 2-methoxycarbonyl-4-t-butoxycarbonylmethyl-6,6-dimethyl-1,5-dioxane (yield 85). %).

【0029】1H−NMR (CDCl3,90MHz):δ
4.70−4.17(m,2H),3.76(s,3H),2.4
1(br,2H),2.13−1.56(m,2H),1.46(m,
15H)
1 H-NMR (CDCl 3 , 90 MHz): δ
4.70-4.17 (m, 2H), 3.76 (s, 3H), 2.4
1 (br, 2H), 2.13-1.56 (m, 2H), 1.46 (m,
15H)

【0030】 元素分析:実測値 C58.38%、H8.42% 計算値 C58.31%、H8.39% (C14246) Elemental analysis: found C 58.38%, H 8.42% calculated C 58.31%, H 8.39% (C 14 H 24 O 6 )

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 式(I): 【化1】 (R1はエステル基、カルボキシル基、又はカルボン酸の
反応性誘導体を表す。R2はアルキル基、アリール基又
はアラルキル基を、R3及びR4は水素又はシリル型保護
基、もしくは共同して環を形成していてもよいアルキル
基を表す。)で示される2,4−ジヒドロキシアジピン酸
エステル誘導体を位置選択的に還元することを特徴とす
る、式(II): 【化2】 (式中、R2、R3及びR4は前記と同意義。)で示される
3,5−ジヒドロキシ−6−オキソヘキサン酸エステル
誘導体の製造法。
1. A compound of the formula (I): (R 1 represents an ester group, a carboxyl group, or a reactive derivative of a carboxylic acid; R 2 represents an alkyl group, an aryl group, or an aralkyl group; R 3 and R 4 represent hydrogen or a silyl-type protecting group; A 2,4-dihydroxyadipate derivative represented by the formula (II): which represents an alkyl group which may form a ring. (Wherein R 2 , R 3 and R 4 have the same meanings as described above.) A method for producing a 3,5-dihydroxy-6-oxohexanoate derivative represented by the formula:
【請求項2】 ヒドリド還元剤を用いて2,4−ジヒド
ロキシアジピン酸ジエステル誘導体を位置選択的に還元
する請求項1記載の製造法。
2. The process according to claim 1, wherein the 2,4-dihydroxyadipate diester derivative is regioselectively reduced using a hydride reducing agent.
【請求項3】 水素化ジイソブチルアルミニウムハイド
ライドを還元剤に用いて2,4−ジヒドロキシアジピン
酸ジエステル誘導体を位置選択的に還元する請求項1ま
たは2記載の製造法。
3. The process according to claim 1, wherein the 2,4-dihydroxyadipate diester derivative is regioselectively reduced using diisobutylaluminum hydride as a reducing agent.
【請求項4】 2,4−ジヒドロキシアジピン酸エステ
ル誘導体として、光学活性な(2S,4R)誘導体を還元
して(3R,5S)−3,5−ジヒドロキシ−6−オキソヘ
キサン酸エステル誘導体を得る請求項1〜3のいずれか
に記載の製造法。
4. An optically active (2S, 4R) derivative is reduced as a 2,4-dihydroxyadipate derivative to obtain a (3R, 5S) -3,5-dihydroxy-6-oxohexanoate derivative. The method according to claim 1.
JP11817099A 1999-04-26 1999-04-26 Method for producing 3,5-dihydroxy-6-oxohexanoate derivative Expired - Fee Related JP3263377B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11817099A JP3263377B2 (en) 1999-04-26 1999-04-26 Method for producing 3,5-dihydroxy-6-oxohexanoate derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11817099A JP3263377B2 (en) 1999-04-26 1999-04-26 Method for producing 3,5-dihydroxy-6-oxohexanoate derivative

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP3046076A Division JP2971966B2 (en) 1990-07-06 1991-02-18 Method for producing 3,5,6-trihydroxyhexanoate derivative

Publications (2)

Publication Number Publication Date
JPH11335328A true JPH11335328A (en) 1999-12-07
JP3263377B2 JP3263377B2 (en) 2002-03-04

Family

ID=14729863

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11817099A Expired - Fee Related JP3263377B2 (en) 1999-04-26 1999-04-26 Method for producing 3,5-dihydroxy-6-oxohexanoate derivative

Country Status (1)

Country Link
JP (1) JP3263377B2 (en)

Also Published As

Publication number Publication date
JP3263377B2 (en) 2002-03-04

Similar Documents

Publication Publication Date Title
JP2009514849A (en) (3R, 5R) -7- [2- (4-Fluorophenyl) -5-isopropyl-3-phenyl-4-[(4-hydroxymethylphenylamino) carbonyl] -pyrrol-1-yl] -3,5 -Preparation of dihydroxy-heptanoic acid hemi-calcium salt
JPH10504845A (en) Process for preparing compounds containing β-hydroxy-δ-lactone groups, analogs of (+)-compactin and (+)-mevinolin
JP4139334B2 (en) New boronate ester
JPH05178849A (en) Optically active fluorinated compound
JPH09328498A (en) Production of 24,25-dihydroxycholesterol and its synthetic intermediate
JP3263377B2 (en) Method for producing 3,5-dihydroxy-6-oxohexanoate derivative
US4325877A (en) Production of intermediates for enzyme inhibitors
JPH0665226A (en) @(3754/24)3r,5s)-3,5,6-trihydroxyhexanoic acid derivative and its production
JP2619136B2 (en) Process for producing 5,6-dihydroxy-3-oxohexanoate derivative
JP2971966B2 (en) Method for producing 3,5,6-trihydroxyhexanoate derivative
JP2006213617A (en) Acetylene aldehyde, its manufacturing method, acetylene aldehyde acetal and its manufacturing method
JP3193597B2 (en) Method for producing glycine derivative
JP4016414B2 (en) Novel dendrimer and method for producing the same
JP2702591B2 (en) 2,4-dihydroxyadipic acid derivative
JP2510613B2 (en) Trifluoroleukotriene derivative and its production method
JP3823668B2 (en) Sphingomyelin analogs and methods for their production
JP3895320B2 (en) Optically active 1,3-propanediol derivative
JP2773118B2 (en) Optically active allyl alcohol derivative
JPH0791223B2 (en) Process for producing optically active 6-t-butoxy-3,5-dihydroxyhexanoic acid ester
JPH0427980B2 (en)
JPH0525089A (en) Production of 2-hydroxy acid derivative
WO2006030892A1 (en) Process for production of heterocyclic compounds
JPH05208969A (en) Optically active fluorine-containing compound
JPH03127792A (en) 4-desoxy-4-epipodophyllotoxin derivative
JPH04316538A (en) Production of optically active 3,5-anti-dihydroxycarboxylic acid ester derivative

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees